The Centers for Disease Control and Prevention (CDC) is the leading national public health agency of the United States, operating under the Department of Health and Human Services. Its mission is to protect public health and safety through the control and prevention of disease, injury, and disability, both domestically and internationally [1]. Established on July 1, 1946, in Atlanta, Georgia, the CDC initially focused on eradicating malaria in the southeastern U.S., evolving rapidly under the vision of Dr. Joseph Mountin into a comprehensive agency addressing a broad spectrum of health threats [2]. Today, the CDC monitors and responds to infectious diseases such as , , , and vector-borne illnesses like Zika and dengue, while also tackling chronic conditions including , heart disease, and . The agency employs advanced epidemiological methods, including like the National Notifiable Diseases Surveillance System (NNDSS) and wastewater monitoring, and leverages cutting-edge technologies such as and through its Advanced Molecular Detection (AMD) program [3]. The CDC collaborates with domestic and international partners, including the World Health Organization (WHO), the Pan American Health Organization (PAHO), and national health ministries, to strengthen global health security [4]. It plays a critical role in emergency response, activating its Emergency Operations Center (EOC) during outbreaks such as the 2022 monkeypox epidemic and the COVID-19 pandemic [5]. The CDC also leads public health initiatives promoting vaccination, tobacco cessation through campaigns like , and chronic disease prevention, all while striving to advance health equity and combat misinformation [6]. Despite its scientific expertise, the agency has faced challenges related to political interference, funding instability, and public trust, particularly during high-profile crises, prompting ongoing reforms to improve transparency, communication, and operational effectiveness [7].
History and Founding of the CDC
The Centers for Disease Control and Prevention (CDC) was established on July 1, 1946, in Atlanta, Georgia, as a direct response to the persistent threat of malaria (paludismo) in the southeastern United States [2]. Originally named the Communicable Disease Center, the agency emerged from the Office of Malaria Control in War Areas (MCWA), a World War II-era initiative launched in 1942 to protect military personnel and civilians from malaria in training zones and war-affected regions [9]. The MCWA’s success in reducing malaria through mosquito control—primarily via widespread use of DDT—demonstrated the effectiveness of coordinated public health interventions and laid the operational foundation for a permanent national agency.
The creation of the CDC was championed by Dr. Joseph W. Mountin, a visionary leader within the U.S. Public Health Service, who advocated for a broader public health mission beyond malaria. Under his leadership, the new agency was strategically headquartered in Atlanta due to its proximity to the malaria-endemic South, allowing for direct field operations and surveillance [2]. Initially operating with a modest budget and fewer than 400 staff, the CDC focused on eradicating local transmission of malaria through vector control, environmental management, and epidemiological monitoring. By 1951, these efforts culminated in the official eradication of malaria from the United States, marking a major public health victory and validating the agency’s scientific and operational approach [11].
Expansion Beyond Infectious Diseases
Following its success with malaria, the CDC rapidly expanded its scope under Dr. Mountin’s guidance. By 1947, it assumed responsibility for monitoring and controlling other infectious diseases such as typhoid fever, rabies, and tuberculosis [2]. This shift reflected a strategic vision of preventive public health, emphasizing surveillance, outbreak investigation, and scientific research. The agency’s role grew further during the 1950s in response to the poliomyelitis (polio) epidemics, where it led national surveillance efforts and supported mass vaccination campaigns, contributing to the eventual decline of the disease [2].
Institutional Evolution and National Leadership
In 1970, the CDC established the Office of Preventive Epidemiology, signaling a shift toward broader public health concerns, including chronic diseases, maternal and child health, and occupational safety. This evolution culminated in 1980 with a formal reorganization into the Centers for Disease Control and Prevention, reflecting its multifaceted mission. The agency adopted a structure of specialized Centers, Institutes, and Offices (CIOs), each dedicated to specific health domains such as infectious diseases, environmental health, and chronic disease prevention [14].
The CDC’s leadership was further solidified during the HIV/AIDS epidemic of the 1980s, when it played a pivotal role in identifying transmission patterns, defining case criteria, and developing prevention strategies. Its publication of the first official report on AIDS in the Morbidity and Mortality Weekly Report (MMWR) in 1981 marked a turning point in the national and global response to the crisis [2]. This experience underscored the importance of rapid surveillance, community engagement, and scientific communication in managing emerging health threats.
Global Health and Modern Challenges
Over the decades, the CDC has become a cornerstone of global health security. Through the Epidemic Intelligence Service (EIS), established in 1951, it has deployed disease detectives worldwide to investigate outbreaks and strengthen public health systems [16]. The agency collaborates with international partners such as the World Health Organization (WHO), the Pan American Health Organization (PAHO), and Africa CDC to enhance disease surveillance, laboratory capacity, and emergency preparedness [4].
Despite its scientific achievements, the CDC has faced challenges related to political influence, funding instability, and public trust, particularly during high-profile crises like the 2001 anthrax attacks, the 2009 H1N1 pandemic, and the COVID-19 pandemic. These events have prompted ongoing reforms to improve transparency, communication, and operational agility. In 2025, the confirmation of Susan Monarez as CDC director marked a significant moment, as she became the first Senate-confirmed director with a mandate to modernize the agency and restore public confidence [7].
Today, the CDC continues to evolve, integrating advanced technologies such as , , and artificial intelligence into its surveillance systems. Its mission remains rooted in the principles established at its founding: protecting public health through science, prevention, and rapid response to emerging threats.
Organizational Structure and Leadership
The Centers for Disease Control and Prevention (CDC) operates under a hierarchical and functionally specialized organizational model designed to efficiently execute its mission of protecting public health. The agency is led by a Director, who serves as the principal advisor to the Secretary of the Department of Health and Human Services (HHS) on public health matters [19]. The Director is supported by the Office of the Director (OD), which provides strategic oversight, coordinates interagency collaboration, and ensures alignment across the agency’s diverse programs and initiatives.
Leadership and Executive Oversight
The CDC Director is appointed by the President of the United States and confirmed by the Senate, reflecting the agency’s critical role in national health policy. In 2025, Susan Monarez became the first CDC Director confirmed by the Senate, marking a significant moment in the agency’s leadership history [7]. Her appointment followed a period of leadership instability, including political interference and high-profile resignations, which underscored the challenges of maintaining scientific independence in a politically charged environment [21]. The Director oversees a leadership team that includes Deputy Directors, Chief Medical Officers, and heads of key offices responsible for science, policy, operations, and equity.
Core Organizational Units: Centers, Institutes, and Offices (CIOs)
The CDC is structured around a decentralized network of Centers, Institutes, and Offices (CIOs), each dedicated to specific public health domains. This modular design enables focused expertise and rapid response to emerging threats. Key components include:
- National Center for Immunization and Respiratory Diseases (NCIRD): Leads efforts in vaccine development, distribution, and respiratory illness surveillance, including seasonal and [22].
- National Center for Emerging and Zoonotic Infectious Diseases (NCEZID): Addresses emerging pathogens such as Zika, dengue, and Ebola, with a focus on zoonotic spillover and antimicrobial resistance.
- National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP): Develops and implements programs targeting major causes of death and disability, including heart disease, , and [23].
- National Center for Environmental Health (NCEH): Monitors environmental hazards such as lead exposure, air pollution, and climate-related health risks, promoting safe environments, especially for children [24].
- National Center for Health Statistics (NCHS): Serves as the nation’s principal health statistics agency, collecting and analyzing data through surveys like the National Health and Nutrition Examination Survey (NHANES) [25].
- National Institute for Occupational Safety and Health (NIOSH): Conducts research and makes recommendations to prevent work-related injuries, illnesses, and fatalities [26].
Supporting these units are critical functional offices, including the Office of Communication, which manages public messaging and risk communication; the Office of Science, which ensures scientific integrity; the Office of Public Health Data, Surveillance, and Technology, which oversees data modernization; and the Office of Policy, Performance, and Evaluation, which aligns programs with strategic goals [19].
Headquarters and Global Presence
The CDC’s primary headquarters is located at 1600 Clifton Road NE, Atlanta, Georgia, a site chosen in 1946 due to its proximity to regions endemic with malaria, the agency’s initial focus [2]. While Atlanta remains the administrative and scientific hub, the CDC maintains a significant national and international footprint. Domestically, it operates regional offices and collaborates with state, local, and tribal health departments. Internationally, the CDC has staff in over 60 countries, working with ministries of health and organizations like the World Health Organization (WHO) and the Pan American Health Organization (PAHO) [29]. A new regional office for Central America and the Caribbean is being established in Panama, enhancing the agency’s capacity to respond to cross-border health threats [30].
This organizational structure allows the CDC to integrate scientific research, surveillance, and public health action across a wide spectrum of health issues. The CIO model promotes agility and specialization, while centralized leadership ensures coherence and strategic direction. However, the agency’s effectiveness is contingent upon stable funding, political independence, and the ability to maintain public trust, challenges that have been particularly evident during recent health crises [31].
Disease Surveillance and Epidemiological Methods
The Centers for Disease Control and Prevention (CDC) employs a comprehensive and multi-layered approach to disease surveillance and epidemiological investigation, integrating traditional public health methods with cutting-edge technologies to detect, track, and respond to health threats. This system is designed to identify outbreaks early, determine sources of infection, and guide timely public health interventions both domestically and globally.
National Surveillance Systems and Data Collection
At the core of the CDC’s surveillance infrastructure is the National Notifiable Diseases Surveillance System (NNDSS), which collects data on over 120 diseases of public health significance from state, local, and territorial health departments [32]. Diseases such as , , , and infections are reported through this system, enabling real-time monitoring of disease trends across the United States. For high-consequence diseases like anthrax, plague, or smallpox, reporting is required immediately by phone, ensuring rapid detection and response [33].
To enhance speed and accuracy, the CDC has modernized data reporting through the National Electronic Disease Surveillance System (NEDSS), which supports secure, standardized electronic transmission of health data [34]. The agency is also advancing the Data Modernization Initiative (DMI), which aims to streamline data flow from clinical settings to public health agencies using interoperable standards like FHIR (Fast Healthcare Interoperability Resources) [35]. This initiative reduces reporting delays and improves data quality by enabling electronic case reporting (eCR) directly from electronic health records (EHRs) [36].
Another innovative system is the National Wastewater Surveillance System (NWSS), which monitors genetic material from pathogens such as SARS-CoV-2, poliovirus, and influenza in community wastewater. This approach provides early warning signals of increasing transmission, even before clinical cases are reported, particularly useful for detecting asymptomatic spread [37]. Similarly, the National Syndromic Surveillance Program (NSSP) analyzes emergency department visit data to identify unusual symptom patterns, such as fever or respiratory distress, that may indicate an emerging outbreak [38].
Advanced Epidemiological Investigation Methods
When an outbreak is detected, the CDC deploys rigorous epidemiological methods to investigate its source and transmission dynamics. A cornerstone of outbreak investigation is the case-control study, a retrospective observational design that compares individuals with the disease (cases) to those without (controls) to identify risk factors [39]. This method is especially valuable for rare diseases or those with long incubation periods. The primary measure of association used is the odds ratio (OR), which estimates the strength of the link between exposure and disease [40].
Field investigations follow the protocols outlined in the CDC’s Field Epidemiology Manual, which guides teams through key steps: confirming the outbreak, defining a case, collecting data via standardized questionnaires, analyzing exposures statistically, and implementing control measures [41]. For foodborne outbreaks, the CDC uses the National Outbreak Reporting System (NORS) to collect data on outbreaks linked to food, water, or person-to-person contact [42]. Statistical tools such as chi-square tests and logistic regression are used to identify significant associations between exposures (e.g., specific foods) and illness.
The CDC also leverages the Program of Epidemic Intelligence Service (EIS), a two-year training program that deploys "disease detectives" to conduct field investigations during outbreaks. These officers play a critical role in identifying sources of infection and recommending containment strategies [43].
Integration of Genomic and Bioinformatics Technologies
A transformative advancement in disease surveillance is the integration of whole genome sequencing (WGS) and bioinformatics through the CDC’s Advanced Molecular Detection (AMD) program [3]. WGS allows for high-resolution characterization of pathogens, enabling precise identification of strains and tracking of transmission chains. For example, the Listeria Genome Sequencing Project has significantly improved the detection of foodborne outbreaks by linking geographically dispersed cases to a common source [45].
The PulseNet system, a national network of public health laboratories, uses WGS to compare bacterial isolates from patients, identifying clusters that suggest a common outbreak [46]. This has been instrumental in detecting multistate outbreaks of Salmonella and Shigella, including a 2023–2024 outbreak of multidrug-resistant Shigella sonnei in California [47]. PulseNet is part of PulseNet International, a global network that enhances cross-border outbreak detection [48].
Bioinformatics pipelines process vast genomic datasets, generating phylogenetic trees that reveal evolutionary relationships between pathogen strains. These tools are critical for detecting antimicrobial resistance, monitoring emerging variants (such as SARS-CoV-2 lineages), and attributing infections to specific sources [49]. The CDC also conducts traveler-based genomic surveillance, with over one million voluntary participants at U.S. airports, to detect emerging viral variants early [50].
Predictive Modeling and Public Health Decision-Making
The CDC uses predictive modeling to forecast disease trends and evaluate intervention strategies. The Center for Forecasting and Outbreak Analytics (CFA) develops mathematical and statistical models to estimate the effective reproductive number (Rt), predict hospitalization surges, and simulate outbreak scenarios [51]. For instance, during the 2025–2026 flu season, the CFA provided real-time estimates of influenza activity, helping health systems prepare for peak demand [52].
The CFA also employs nowcasting techniques to adjust for reporting delays and provide more accurate real-time situations [53]. Simulators, such as the measles outbreak simulator, allow public health officials to assess the impact of vaccination coverage levels on outbreak size and duration [54]. These models are essential for guiding decisions on vaccination campaigns, school closures, and resource allocation during emergencies.
Data Interpretation, Communication, and Equity
Transforming raw data into actionable public health guidance requires robust analysis and clear communication. The CDC uses the Framework for Program Evaluation in Public Health (2024) to ensure that surveillance systems are timely, sensitive, and representative [55]. Findings are communicated through public health alerts, weekly reports like the FluView, and simplified guidance documents for clinicians and the public [56].
Recognizing the impact of misinformation and political interference, the CDC has strengthened its risk communication strategies. The Crisis and Emergency Risk Communication (CERC) program provides training and tools to ensure messages are clear, empathetic, and culturally appropriate [57]. Lessons from the pandemic highlighted the need for consistent messaging, leading to reforms that emphasize transparency and community engagement [58].
Equity is a central focus, with the CDC using tools like the Environmental Justice Index (EJI) to identify communities disproportionately affected by environmental and health risks [59]. Surveillance data are disaggregated by race, ethnicity, and socioeconomic status to ensure that interventions reach underserved populations and reduce disparities in disease burden.
In summary, the CDC’s disease surveillance and epidemiological methods combine traditional field investigation with advanced technologies such as , , and predictive modeling. These integrated approaches enable rapid detection, precise source attribution, and evidence-based public health action, forming the foundation of national and global health security.
Response to Infectious Disease Threats
The Centers for Disease Control and Prevention (CDC) plays a central role in detecting, investigating, and responding to infectious disease threats both domestically and globally. Through a combination of advanced surveillance systems, rapid epidemiological investigation, and coordinated emergency response, the CDC works to contain outbreaks, prevent transmission, and protect public health. Its response capabilities are grounded in scientific rigor, interagency collaboration, and the use of cutting-edge technologies such as and .
Detection and Surveillance of Infectious Disease Threats
Early detection is critical to an effective response, and the CDC employs a multi-layered system of surveillance to identify emerging infectious disease threats. The cornerstone of this system is the , which collects data from state, local, and territorial health departments on over 120 nationally notifiable conditions, including , , , and foodborne pathogens like and [32]. This data enables real-time monitoring of disease trends and the identification of unusual clusters that may signal an outbreak.
In addition to clinical reporting, the CDC utilizes innovative surveillance methods such as the , which detects viral genetic material in community wastewater. This system provides early warning signals for diseases like , , and even before clinical cases are reported, allowing for proactive public health measures [37]. Another key tool is the , which analyzes emergency department visit data to detect increases in symptoms such as fever, cough, or gastrointestinal illness, often before a specific pathogen is identified [38].
The CDC also leverages global surveillance networks like , which connects laboratories worldwide to detect foodborne outbreaks through genomic fingerprinting of bacterial pathogens [48]. In Latin America and the Caribbean, the CDC supports the expansion of and , enhancing regional capacity for genomic surveillance [64].
Investigation and Epidemiological Response
When a potential outbreak is detected, the CDC deploys its expertise in epidemiological investigation to determine the source, mode of transmission, and appropriate control measures. A primary method used is the , in which individuals with the disease (cases) are compared to those without (controls) to identify risk factors. This approach has been instrumental in linking outbreaks to specific exposures, such as contaminated food products or travel to affected areas [39].
The CDC's field epidemiology teams, including officers from the , conduct on-the-ground investigations to collect data, interview patients, and gather environmental samples. These efforts are guided by the CDC’s Field Epidemiology Manual, which outlines standardized procedures for outbreak response [41]. For example, in a 2026 outbreak of Salmonella linked to dietary supplements, the CDC used case-control studies and genomic sequencing to identify the source and support a product recall [67].
The integration of has revolutionized outbreak detection and investigation. Through the program, the CDC analyzes pathogen genomes to distinguish between related and unrelated cases, trace transmission chains, and detect antimicrobial resistance [3]. This technology was critical in identifying and containing outbreaks of drug-resistant Shigella sonnei in California and Candida auris in healthcare settings [47], [70].
Emergency Response and Operational Coordination
To coordinate rapid and effective responses to major infectious disease threats, the CDC activates its , which serves as a central hub for incident management, resource allocation, and interagency coordination. The EOC was activated during the 2022 monkeypox outbreak and the , enabling a unified national response involving federal, state, and international partners [5].
The CDC operates under the framework, which ensures clear roles, communication protocols, and decision-making structures during emergencies [72]. This system facilitates collaboration with other federal agencies, including the for medical countermeasures, the for border health measures, and the for logistical support.
International coordination is also a key component of the CDC’s response strategy. The agency maintains offices in over 60 countries and collaborates with organizations such as the , the , and the to strengthen global health security [29]. For instance, the CDC supported the launch of a collaborative surveillance partnership between the WHO, Africa CDC, and the to enhance disease detection in Africa [74].
Communication and Public Health Messaging
Effective communication is essential for maintaining public trust and ensuring adherence to preventive measures during infectious disease outbreaks. The CDC employs the framework to deliver timely, clear, and actionable information to the public, healthcare providers, and policymakers [57]. This includes issuing public health alerts, updating guidance documents, and conducting media briefings.
During the , the CDC faced criticism for inconsistent messaging and delays in updating recommendations, which contributed to public confusion and eroded trust [58]. In response, the agency has implemented reforms to improve transparency and clarity, including the simplification of guidance on respiratory viruses and the launch of a redesigned website to enhance accessibility [77].
The CDC also prioritizes equity in its communication strategies, recognizing that marginalized communities may face disproportionate risks and barriers to information. It has developed culturally tailored materials and partnered with community organizations to increase vaccine confidence and promote preventive behaviors, particularly among racial and ethnic minorities, LGBTQ+ populations, and rural communities [78].
Challenges and Adaptations in Infectious Disease Response
Despite its robust capabilities, the CDC faces ongoing challenges in responding to infectious disease threats. Political interference has at times compromised the agency’s scientific independence, as seen in 2025 when the confirmation of a new director followed allegations of pressure to align vaccine recommendations with non-scientific agendas [79]. Additionally, proposed budget cuts threaten the sustainability of critical programs, including data modernization and laboratory infrastructure [80].
The agency continues to adapt by investing in data modernization through initiatives like the and the adoption of interoperable standards such as to streamline data exchange between healthcare providers and public health agencies [81]. These efforts aim to overcome historical delays in reporting and improve the timeliness of outbreak detection.
In conclusion, the CDC’s response to infectious disease threats is a dynamic, science-driven process that integrates surveillance, epidemiology, emergency management, and communication. While challenges remain, the agency continues to evolve its strategies to meet emerging threats, guided by a mission to protect health through prevention, rapid response, and equitable public health action.
Chronic Disease Prevention and Health Promotion
The Centers for Disease Control and Prevention (CDC) plays a central role in the prevention and control of chronic diseases, which are among the leading causes of death and disability in the United States. Through evidence-based programs, surveillance systems, and community partnerships, the CDC works to reduce the burden of conditions such as , heart disease, , and chronic respiratory diseases. These efforts are coordinated by the National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP), a key component of the CDC’s organizational structure [82].
Surveillance and Data-Driven Prevention Strategies
A cornerstone of the CDC’s approach to chronic disease prevention is robust surveillance. Unlike infectious diseases, which are often notifiable, chronic diseases require long-term monitoring through population-based surveys and administrative data. The CDC relies heavily on tools such as the Behavioral Risk Factor Surveillance System (BRFSS), a nationwide telephone survey that collects data on health risk behaviors, chronic conditions, and preventive practices [83]. This system enables public health officials to track trends in smoking, obesity, physical inactivity, and other modifiable risk factors across states and demographic groups.
Additionally, the CDC uses data from the National Health and Nutrition Examination Survey (NHANES) and electronic health records (EHRs) to estimate disease prevalence and identify disparities. Recent advancements include the use of latent class analysis to segment populations by risk profiles, improving the precision of prevention strategies [84]. These data inform targeted interventions and help allocate resources to communities with the greatest need.
Evidence-Based Programs for Disease Prevention
The CDC supports and promotes several evidence-based programs designed to prevent chronic diseases and promote long-term health. One of the most impactful is the National Diabetes Prevention Program (DPP), a lifestyle change initiative aimed at individuals with prediabetes. The program, delivered through community organizations, healthcare systems, and virtual platforms, helps participants reduce their risk of developing type 2 diabetes by up to 58% through structured goals for weight loss, improved nutrition, and increased physical activity [85]. The DPP has been validated by multiple studies, including Cochrane reviews, and is offered in both English and Spanish to improve accessibility [86].
Another major initiative is the High Obesity Program (HOP), which partners with cooperative extension services to address obesity in rural communities where adult obesity rates exceed 35%. The program focuses on creating supportive environments for healthy eating and active living through policy, systems, and environmental changes [87]. Similarly, the COMMIT! (Community Measures of Obesity) program assists federally qualified health centers in implementing weight management services for children and adolescents [88].
Addressing Health Equity in Chronic Disease Interventions
The CDC prioritizes health equity in its chronic disease prevention efforts, recognizing that conditions like diabetes and heart disease disproportionately affect racial and ethnic minority populations. For example, Hispanic and non-Hispanic Black adults have higher rates of diabetes compared to non-Hispanic White adults, with disparities influenced by socioeconomic factors, access to care, and environmental barriers [89]. To address these inequities, the CDC funds programs such as REACH (Racial and Ethnic Approaches to Community Health), which supports community-led initiatives to improve nutrition, increase physical activity, and expand access to preventive services in underserved areas [90].
The CDC also evaluates program effectiveness using frameworks like RE-AIM (Reach, Effectiveness, Adoption, Implementation, Maintenance), which assesses not only clinical outcomes but also the real-world sustainability and equity of interventions [90]. This ensures that programs are not only effective in controlled trials but also scalable and beneficial to marginalized populations.
Promoting Environmental and Policy-Level Changes
Beyond individual-level interventions, the CDC advocates for structural and policy changes that create healthier communities. This includes supporting policies such as sugary drink taxes, improved food labeling, and the development of walkable urban environments. The agency also promotes school and workplace wellness programs and collaborates with urban planners and public health departments to design communities that encourage physical activity and healthy eating [92].
Environmental factors such as air quality and access to green spaces are also considered in the CDC’s chronic disease strategy. The agency works with the Environmental Protection Agency (EPA) and local health departments to monitor and mitigate environmental risks that exacerbate chronic conditions like asthma and cardiovascular disease.
Evaluation and Continuous Improvement
The CDC employs a rigorous Program Evaluation Framework to assess the impact of its chronic disease initiatives. Updated in 2024, this framework guides public health professionals through six steps: engaging stakeholders, describing the program, focusing the evaluation, collecting evidence, justifying conclusions, and ensuring use and dissemination of findings [93]. This systematic approach ensures that programs are continuously refined based on data and community feedback.
In conclusion, the CDC’s approach to chronic disease prevention and health promotion is comprehensive, integrating surveillance, evidence-based interventions, equity-focused programming, and policy advocacy. By addressing both individual behaviors and systemic determinants of health, the agency aims to reduce the prevalence of chronic diseases and improve the overall well-being of the U.S. population.
Global Health and International Collaboration
The Centers for Disease Control and Prevention (CDC) plays a pivotal role in global health security by leading and supporting international efforts to prevent, detect, and respond to infectious disease threats that transcend national borders. Through a network of partnerships, technical expertise, and on-the-ground presence, the CDC strengthens public health systems worldwide, protects populations from emerging pathogens, and advances the principles of One Health, which recognizes the interconnectedness of human, animal, and environmental health [94].
International Partnerships and Multilateral Collaboration
The CDC’s global impact is amplified through strategic alliances with key international organizations. Its collaboration with the World Health Organization (WHO) is foundational, involving joint efforts in disease surveillance, emergency response, and the implementation of the International Health Regulations (IHR). The CDC provides critical technical support to the WHO, particularly in regions with fragile health systems. However, this partnership has faced significant challenges due to political decisions, such as the United States' formal withdrawal from the WHO in 2020 under the Trump administration and a subsequent order in January 2025 from President Trump to sever all communication and collaboration between the CDC and the WHO, which severely disrupted global health coordination [95].
The CDC also maintains a robust partnership with the Pan American Health Organization (PAHO), the regional office of the WHO for the Americas. Together, they work to strengthen health systems, improve access to essential medicines and vaccines, and combat diseases like dengue and Zika [4]. In 2024, PAHO and Africa CDC signed an agreement to enhance access to vaccines, with technical support from the CDC [97]. Furthermore, the CDC collaborates with the Robert Koch Institute (RKI) in Germany to bolster disease surveillance in Africa, an initiative that was expanded in 2025 to include more countries and improve collaborative monitoring [98].
Global Disease Surveillance and Laboratory Networks
A cornerstone of the CDC’s international work is its support for global disease surveillance systems. The agency operates in over 60 countries, deploying staff and providing funding to build local capacity for early detection and rapid response. It supports the development of national public health institutes and strengthens laboratory networks to ensure timely and accurate diagnosis of pathogens. The CDC’s Advanced Molecular Detection (AMD) program leverages and to track the evolution and spread of diseases, a capability that has been shared with partner countries to enhance their own surveillance efforts [3].
One of the most significant global networks is PulseNet International, which connects public health laboratories across the world to detect foodborne disease outbreaks using genomic fingerprinting. The CDC supports regional networks like PulseNet Latin America and the Caribbean (PNALC) and PAHOGen, which have been instrumental in identifying and stopping multistate outbreaks of Salmonella and other pathogens [64]. The agency also conducts surveillance at international points of entry, such as airports, with a biosurveillance program that has surpassed one million voluntary air travelers, helping to detect emerging variants of viruses like SARS-CoV-2 [50].
Binational and Regional Initiatives
The CDC implements targeted programs to address health threats in specific regions. A key example is the U.S.-Mexico Binational Border Infectious Disease Surveillance (BIDS) Program, which enhances joint detection and response to diseases such as tuberculosis, influenza, and antimicrobial resistance along the shared border [102]. This program exemplifies the importance of cross-border cooperation in managing public health risks in an interconnected world.
The CDC is also expanding its regional footprint. In 2024, it announced plans to establish a new regional office for Central America and the Caribbean in Panama, which will serve as a hub for technical assistance, training, and coordination of public health activities in the region [30]. This expansion aims to strengthen regional preparedness and response to emerging health threats.
Global Response to Emerging Threats and Pandemics
The CDC is a leader in the global response to pandemics and emerging infectious diseases. It activates its Emergency Operations Center (EOC) to coordinate international responses, as it did during the 2022 mpox outbreak and the COVID-19 pandemic [5]. Through the Global VAX and COVAX initiatives, the CDC supported equitable access to COVID-19 vaccines in low- and middle-income countries [105]. The agency also sends experts through the Stop Transmission of Polio (STOP) program to help countries strengthen immunization systems and prevent outbreaks of vaccine-preventable diseases [106].
The CDC’s global reach was evident in its response to a mysterious disease in the Congo in 2025 that caused over 50 deaths in less than 48 hours, demonstrating its role in the early detection of potential global threats [107]. Its epidemiologists, trained through the Epidemic Intelligence Service (EIS), are deployed worldwide to investigate outbreaks and build local capacity, making the CDC a critical first responder in the global health security architecture.
Challenges in Global Health Governance and Equity
Despite its extensive efforts, the CDC faces significant challenges in its international work. A major issue is the inequity in the sharing of data and pathogens. The head of Africa CDC has expressed serious concerns about U.S. health deals with African nations, citing a lack of fair benefit-sharing and equitable access to vaccines derived from African samples [108]. This highlights a structural asymmetry in global health governance that can undermine trust and cooperation.
Furthermore, the agency’s global effectiveness is vulnerable to domestic political decisions and funding instability. Proposed budget cuts and political interference can weaken its international programs and diminish its leadership role on the world stage [109]. The success of the CDC’s global mission ultimately depends on sustained investment, respect for scientific independence, and a commitment to building equitable and resilient health systems for all.
Public Health Communication and Risk Messaging
The Centers for Disease Control and Prevention (CDC) plays a central role in public health communication and risk messaging, utilizing a comprehensive framework to inform, guide, and protect the public during health emergencies. The agency's communication strategy is built on evidence-based principles, aiming to deliver timely, accurate, and actionable information while navigating challenges such as misinformation, political interference, and public distrust. Its approach integrates scientific rigor with cultural sensitivity to ensure messages are accessible and effective across diverse populations.
Crisis and Emergency Risk Communication (CERC) Framework
At the core of the CDC’s communication strategy is the Crisis and Emergency Risk Communication (CERC) framework, a science-based methodology designed to help public health professionals communicate effectively during emergencies [57]. This framework emphasizes key principles such as transparency, empathy, consistency, and timeliness. The CERC model provides training and resources for health communicators, emergency responders, and community leaders to ensure coordinated messaging during outbreaks, natural disasters, and other public health crises [57]. During the 2022 mpox outbreak, the CDC activated its Emergency Operations Center (EOC) to coordinate messaging, disseminate prevention guidance, and support local health departments in delivering consistent information [112].
The CERC framework also emphasizes the importance of audience segmentation and community engagement. Recognizing that different populations may respond differently to health messages, the CDC tailors its communication to specific groups, including racial and ethnic minorities, people with disabilities, and LGBTQ+ communities. This approach helps build trust and ensures that public health recommendations are both understood and adopted.
Challenges in Communication During the COVID-19 Pandemic
The pandemic of exposed significant weaknesses in the CDC’s public health messaging. Despite its scientific expertise, the agency faced widespread criticism for inconsistent, confusing, and frequently changing guidance on issues such as mask-wearing, social distancing, and quarantine protocols [58]. These inconsistencies, often driven by evolving scientific understanding, were perceived by the public as indecisiveness or lack of credibility, contributing to a decline in trust [114]. Former CDC Director Rochelle Walensky acknowledged these failures in 2022, stating that the agency’s communication during the early stages of the pandemic was flawed and required significant improvement [115].
Political interference further undermined the CDC’s messaging. Reports indicated that during the Trump administration, political appointees altered scientific reports and pressured the agency to align its recommendations with political narratives, particularly regarding school reopenings and the severity of the virus [116]. This politicization of science eroded public confidence and complicated efforts to promote evidence-based behaviors.
Combating Misinformation and Building Trust
To counter the spread of misinformation, the CDC has strengthened its efforts to monitor and respond to false narratives, particularly on social media platforms. The agency has developed tools and guidelines to help community partners identify and mitigate the effects of vaccine-related misinformation, especially in racial and ethnic minority communities [117]. For example, the CDC has published fact-checking resources to refute false claims, such as the debunked link between vaccines and autism, reinforcing that no scientific evidence supports such a connection [118].
The CDC also collaborates with trusted community leaders, including religious figures, healthcare providers, and local organizations, to amplify credible health messages. Programs like the Partnering for Vaccine Equity (P4VE) initiative fund community-based organizations to conduct outreach and education campaigns tailored to specific cultural contexts [119]. One notable success was the “Esperanza Hope for All” campaign, led by UnidosUS with CDC support, which vaccinated over 644,000 people and trained thousands of community health promoters [120].
Communication Equity and Inclusive Messaging
Recognizing that health disparities are often rooted in social and structural inequities, the CDC has prioritized equity in its communication strategies. The agency has developed Guiding Principles for Inclusive Communication to ensure that public health messages are respectful, accessible, and culturally appropriate [121]. These principles guide the use of language, imagery, and outreach methods to avoid stigmatization and promote inclusivity.
The CDC also produces materials in multiple languages, including Spanish, to reach non-English-speaking populations. For instance, the Tips From Former Smokers campaign features real stories from former smokers of diverse backgrounds, highlighting the health consequences of tobacco use and encouraging cessation [6]. The campaign has been highly effective, with over 16.4 million smokers attempting to quit and approximately 1 million successfully quitting between 2012 and 2018 [123].
Modernization and Future Directions
In response to past communication failures, the CDC has launched a comprehensive modernization effort to improve the clarity, speed, and impact of its public health messaging. In 2024, the agency unveiled a redesigned website, CDC.gov, with a more user-friendly interface and simplified content to enhance public understanding [124]. The agency has also adopted new standards for data sharing and communication, including the use of Fast Healthcare Interoperability Resources (FHIR) to streamline the exchange of public health information between systems [81].
To ensure long-term effectiveness, the CDC continues to invest in workforce development and community engagement. In 2024, it allocated over $176 million to strengthen public health infrastructure and train professionals in risk communication and health equity [126]. These efforts are critical to rebuilding trust and ensuring that the CDC remains a credible, science-based source of information in future public health emergencies.
Biosecurity, Laboratory Safety, and Ethical Research
The Centers for Disease Control and Prevention (CDC) plays a central role in governing biosecurity and laboratory safety, particularly in high-containment facilities such as Biosafety Level 4 (BSL-4) and BSL-3 laboratories. While the CDC does not possess direct regulatory authority to impose legal sanctions, it exercises significant technical and normative leadership by developing and disseminating science-based guidelines that are widely adopted across the United States and internationally. Its primary tool for this function is the Biosafety in Microbiological and Biomedical Laboratories (BMBL), a comprehensive document jointly developed with the National Institutes of Health (NIH) and updated regularly, including a sixth edition released in 2020 with ongoing revisions through 2025 [127]. The BMBL provides risk-based recommendations for handling infectious agents and is considered a mandatory reference by accreditation bodies, federal funders, and institutional biosafety committees, despite not being a legally binding regulation [128].
To strengthen oversight of the highest-risk laboratories, the CDC has proposed a Draft Policy Statement for Biosafety Level 4 (BSL-4) and Animal BSL-4 (ABSL-4) Laboratory Verification, published in 2022. This framework aims to establish a formal system of verification and certification for BSL-4 facilities, which handle extremely dangerous pathogens such as the Ebola virus and Marburg hemorrhagic fever virus [129]. The proposed standards include stringent requirements for physical design, access controls, HEPA filtration systems, decontamination protocols, and specialized personnel training. The CDC also issues inspection checklists for BSL-3 laboratories, aligning them with federal regulations such as 42 CFR Part 73, which governs the possession, use, and transfer of select agents and toxins [130]. Furthermore, the agency promotes workforce competency through guidelines like the Guidelines for Biosafety Laboratory Competency, ensuring that laboratory personnel are adequately trained to handle high-consequence pathogens safely [131].
Balancing Safety, Ethics, and Regulation in High-Risk Research
The CDC balances the technical demands of biosecurity with ethical and regulatory considerations, particularly in research involving human subjects and dual-use research of concern (DURC). For studies involving human participants, the CDC mandates review by Institutional Review Boards (IRBs) and adherence to international ethical principles, including informed consent, risk minimization, and justice in participant selection [132]. This is especially critical for controlled human infection models (CHIM), such as those used in research on dengue or malaria, where volunteers are deliberately exposed to pathogens. In these cases, the CDC follows guidance from the Pan American Health Organization (PAHO) and the World Health Organization (WHO), which establish strict criteria for ethical acceptability during public health emergencies [133][134].
A critical aspect of this balance is the oversight of DURC—research that, while legitimate, could be misused to cause harm. In May 2024, the U.S. government updated its oversight policy to include not only DURC but also research involving enhanced potential pandemic pathogens (ePPP), establishing a pre-review framework for studies with Category 1 and 2 agents [135]. The CDC actively participates in this process, ensuring that institutions funded or supervised by the Department of Health and Human Services (HHS) implement appropriate controls. The agency also addresses broader ethical concerns, such as equity in the sharing of data and pathogens, which has been a point of contention in international collaborations [108].
Global Leadership and Capacity Building in Laboratory Biosafety
The CDC extends its influence in biosecurity through international collaboration and capacity building. It has been designated a Collaborating Center by the Pan American Health Organization (PAHO) and the WHO for biosafety and biosecurity, supporting countries in Latin America and the Caribbean in the safe management of high-risk laboratories [137]. This support includes technical assistance, training, and help with laboratory certification, such as the recertification of the BSL-3 laboratory at the Universidad de Monterrey in Mexico [138]. A significant milestone in regional capacity building was the inauguration in 2025 of the first BSL-4 laboratory in Latin America at the ANLIS Malbrán in Argentina, developed with technical support and training from the CDC [139]. This facility enhances regional preparedness for emerging diseases and reflects a broader effort to strengthen global health security.
Despite these advancements, the CDC's governance role has been shaped by past incidents, such as safety lapses in laboratories handling anthrax and avian influenza, which led to temporary closures and prompted the development of more robust policies [140][141]. These events underscore the importance of continuous improvement in safety culture and oversight. The CDC’s comprehensive approach—combining technical guidance, ethical oversight, and global partnership—ensures that research with dangerous pathogens advances scientific knowledge while safeguarding public health, laboratory workers, and the environment.
Health Equity and Community-Based Interventions
The Centers for Disease Control and Prevention (CDC) prioritizes health equity as a foundational element of its mission, aiming to eliminate disparities and ensure that all individuals have the opportunity to achieve optimal health. This commitment is operationalized through community-based interventions that are culturally responsive, evidence-based, and designed to reach populations historically underserved by public health systems. By addressing the social determinants of health and engaging communities as partners, the CDC works to reduce the disproportionate burden of disease and improve outcomes across racial, ethnic, socioeconomic, and geographic lines [1].
Addressing Health Disparities Through Targeted Programs
The CDC recognizes that systemic inequities contribute to higher rates of chronic and infectious diseases among marginalized populations. To combat these disparities, the agency implements targeted initiatives such as the Racial and Ethnic Approaches to Community Health (REACH) program, which funds community-led efforts to prevent chronic diseases like and heart disease in populations facing structural barriers. REACH supports interventions that improve access to healthy foods, promote physical activity, and enhance healthcare access in communities of color, including African American, Hispanic/Latino, and Indigenous populations [90].
Similarly, the CDC’s focus on environmental justice addresses how low-income and minority communities are disproportionately exposed to hazards such as lead, air pollution, and toxic waste. Through the Agency for Toxic Substances and Disease Registry (ATSDR), the CDC provides tools like the Environmental Justice Index (EJI) to identify communities at high risk and guide resource allocation [59]. This data-driven approach enables targeted public health actions that reduce environmental health disparities.
Community-Based Prevention of Chronic Diseases
Community-based programs are central to the CDC’s strategy for preventing chronic diseases, particularly in high-risk populations. The National Diabetes Prevention Program (DPP) is a prime example of an evidence-based intervention that has been successfully adapted for diverse communities. This lifestyle change program helps individuals with reduce their risk of developing by 58% through structured support in weight loss, nutrition, and physical activity [85].
To ensure equitable access, the CDC certifies DPP providers in community settings such as churches, health centers, and workplaces, particularly in underserved areas. The program emphasizes cultural adaptation, offering materials in multiple languages—including Spanish—and training community health workers to deliver the curriculum. Evaluations using the RE-AIM framework (Reach, Efficacy, Adoption, Implementation, Maintenance) have demonstrated the program’s effectiveness in real-world settings and its potential to reduce diabetes disparities [90].
Another initiative, the High Obesity Program (HOP), targets rural communities where adult obesity rates exceed 35%. HOP collaborates with agricultural extension services to implement strategies such as community gardens, farmers’ markets, and safe walking paths, recognizing that structural factors like food deserts and limited recreational infrastructure contribute to poor health outcomes [87].
Tobacco Cessation and Health Equity
Tobacco use remains a leading cause of preventable death, with significant disparities across populations. The CDC’s Tips From Former Smokers campaign is a powerful tool for promoting cessation, particularly among vulnerable groups. The campaign features real stories from individuals affected by smoking-related illnesses, including African Americans, Hispanic/Latino individuals, LGBTQ+ people, and military veterans [6].
By highlighting the specific risks of menthol cigarettes—disproportionately marketed to Black communities—the campaign addresses both behavioral and structural aspects of tobacco use. Since its launch, the campaign has prompted over 16 million quit attempts and contributed to more than 1 million successful quit attempts [123]. The CDC also supports access to free cessation resources, such as the 1-800-QUIT-NOW hotline and FDA-approved medications, ensuring that cost is not a barrier to quitting.
Vaccine Equity and Community Engagement
The CDC plays a critical role in promoting vaccine equity, particularly during pandemics and seasonal outbreaks. To increase acceptance and access, the agency has launched initiatives like the Bridge Access Program, which provides free and to uninsured or underinsured adults through community pharmacies and health centers [150].
The CDC also supports the Partnering for Vaccine Equity (P4VE) program, which funds community-based organizations to conduct outreach in racial and ethnic minority communities. One notable success is the Esperanza Hope for All campaign, led by UnidosUS with CDC support, which vaccinated over 644,000 people and trained thousands of community health promoters [120].
To combat vaccine hesitancy, the CDC collaborates with trusted community leaders, including faith-based organizations and local influencers, to deliver culturally appropriate messages. The agency also provides toolkits for community partners to address misinformation and build trust, recognizing that effective communication must be rooted in cultural humility and community voice [152].
Integrating Equity into Public Health Practice
The CDC institutionalizes health equity through its Strategic Plan 2022–2027, which identifies equity as a core principle across all agency activities [153]. This includes integrating equity into clinical guidelines, surveillance systems, and program evaluation. For example, the CDC’s Program Evaluation Framework requires that evaluations assess outcomes by demographic and socioeconomic factors to identify and address disparities [93].
The agency also promotes inclusive communication through its Guiding Principles for Inclusive Communication, which emphasize the use of respectful language, accessibility for people with disabilities, and engagement with diverse communities in message development [155]. These principles guide the CDC’s efforts to ensure that public health information is not only accurate but also accessible and empowering.
In conclusion, the CDC’s approach to health equity and community-based interventions reflects a deep commitment to justice and inclusion in public health. By investing in programs that are culturally relevant, community-driven, and grounded in evidence, the agency works to dismantle systemic barriers and ensure that all people—regardless of background—can live healthier lives. These efforts are essential for building resilient communities and achieving the broader goal of health for all.
Challenges in Policy, Funding, and Public Trust
The Centers for Disease Control and Prevention (CDC) has faced persistent and multifaceted challenges related to policy decisions, funding instability, and declining public trust, particularly during high-profile health crises. These challenges have significantly impacted its operational effectiveness, scientific independence, and ability to implement evidence-based public health measures. Political interference, fluctuating budgets, and the spread of disinformation have collectively undermined the agency’s authority and weakened its capacity to protect public health both domestically and globally [7].
Political Interference and Erosion of Scientific Autonomy
One of the most significant challenges confronting the CDC is political interference in its scientific and public health decisions. The agency’s authority is derived from the , which grants it powers to regulate the interstate spread of communicable diseases [157]. However, its operational independence has been compromised during periods of heightened political influence. For example, during the Trump administration, there were documented instances of political pressure on CDC reports, including modifications to school reopening guidelines and downplaying the severity of the pandemic, which eroded the agency’s credibility [116].
This trend intensified in 2025 when Secretary of Health Robert F. Kennedy Jr., known for his anti-vaccine stance, reportedly pressured CDC officials to align vaccination recommendations with non-scientific viewpoints. Susan Monarez, then acting director, was dismissed after refusing to approve vaccine recommendations without scientific evidence, highlighting a crisis of scientific integrity within the agency [21]. In January 2025, President Donald Trump ordered a complete halt to all communication and collaboration between the CDC and the World Health Organization (WHO), severely disrupting global health coordination [95]. These actions have raised alarms about the politicization of public health and the long-term consequences for the CDC’s role as a science-driven institution.
Funding Instability and Budgetary Pressures
The CDC’s ability to fulfill its mission is heavily dependent on annual appropriations from Congress, making it vulnerable to shifting political priorities and budget cuts. In 2026, the proposed budget for the CDC was approximately $4.243 billion, but this figure has been subject to intense legislative debate, with proposals threatening significant reductions to key programs [109]. A notable example of funding instability occurred in 2024 when Congress withdrew financial support for the CDC’s response, affecting surveillance, testing, vaccination efforts, and support for state and local health departments [162]. Experts from George Washington University warned that these cuts not only weakened emergency preparedness but also had negative economic impacts on state and local economies [163].
Furthermore, proposed legislation such as the “One Big Beautiful Act” (OBBA), enacted in 2025, could indirectly affect CDC initiatives by restructuring Medicaid, thereby altering the flow of funds to state-level prevention and disease control programs [164]. The HHS Office of Inspector General has emphasized the need for improved coordination across emergency preparedness programs to optimize the use of limited resources [165]. Without stable and sufficient funding, the CDC’s capacity to maintain robust , respond to emerging threats like or outbreaks, and implement long-term strategies such as the first national plan is severely constrained [166].
Declining Public Trust and the Infodemic
Public trust in the CDC has declined significantly, particularly during the pandemic, due to perceived inconsistencies in messaging, delays in updating guidance, and the influence of political actors. Early in the pandemic, the CDC issued confusing recommendations on mask-wearing and social distancing, which, although reflective of evolving scientific understanding, were perceived as contradictory and damaged public confidence [58]. In 2022, the CDC acknowledged these failures and simplified its guidance to improve clarity and public comprehension [168].
The proliferation of disinformation on social media platforms further exacerbated the crisis of trust. False narratives about the origin of the virus, the safety of vaccines, and the efficacy of treatments spread rapidly, undermining the CDC’s efforts to promote evidence-based behaviors [114]. The agency has since launched initiatives to combat misinformation, including a “practical playbook” for addressing health misinformation and enhanced monitoring of false claims [170]. However, the damage to its reputation persists, especially among politically polarized groups and historically marginalized communities that have experienced systemic inequities in healthcare.
Legal and Ethical Challenges in Implementing Public Health Measures
The CDC also faces legal limitations in enforcing public health mandates, which complicates its response to outbreaks. While it has authority under federal law to impose quarantine for diseases like cholera, plague, and yellow fever, its power to enforce nationwide measures such as mask mandates or vaccination requirements is constrained. In 2022, a federal court ruled that the CDC’s mask mandate for public transportation was unlawful, prompting the agency to reassess the necessity of such orders [171]. This judicial pushback reflects broader legal debates over the balance between public health and individual liberties.
Ethically, the CDC must navigate complex issues such as dual-use research of concern (DURC) and research involving enhanced potential pandemic pathogens (ePPP), which could be misused for harmful purposes [135]. The agency participates in federal oversight mechanisms to ensure that such research adheres to strict biosafety and biosecurity standards. Additionally, the CDC emphasizes the protection of human subjects in clinical trials, requiring Institutional Review Board (IRB) approval and informed consent, particularly in studies involving deliberate infection with pathogens like dengue or malaria [132].
Institutional Reforms and the Path Forward
In response to these challenges, the CDC has initiated reforms aimed at restoring trust, improving communication, and enhancing operational resilience. In 2024, the agency launched a redesigned website with clearer language and user-friendly navigation to improve public access to health information [124]. It has also adopted guiding principles for inclusive communication, emphasizing cultural sensitivity, accessibility for people with disabilities, and engagement with community leaders [155]. The 2025 confirmation of Susan Monarez as the first Senate-confirmed CDC director signaled a renewed commitment to scientific integrity and transparency, although her subsequent resignation under political pressure underscored the fragility of this progress [7].
The agency continues to strengthen its partnerships with organizations like the Pan American Health Organization (PAHO) and local community groups to ensure that interventions are equitable and culturally appropriate [4]. By integrating equity into its core strategies—from vaccine distribution to chronic disease prevention—the CDC aims to address historical disparities and rebuild public confidence. However, its long-term effectiveness will depend on sustained funding, protection from political interference, and a steadfast commitment to science-based decision-making in an increasingly complex public health landscape.